Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.

What is Rheumatoid Arthritis?

Rheumatoid arthritis or RA is an inflammatory condition that affects joints primarily leading to pain and stiffness and difficulty in movements. Commonly affected joints are those of the hands, feet and wrists. RA however can also affect other parts of the body.

Rheumatoid Arthritis Epidemiology

Rheumatoid Arthritis and Exercise

Rheumatoid Arthritis Treatment

Rheumatoid Arthritis Symptoms

Rheumatoid Arthritis Nodules

Psoriatic Arthritis vs Rheumatoid Arthritis

Rheumatoid Arthritis and Pregnancy

Juvenile Rheumatoid Arthritis Treatment

Juvenile Rheumatoid Arthritis Symptoms

Rheumatoid Arthritis Skin Problems

Juvenile Rheumatoid Arthritis

See more featured articles »

What Causes Rheumatoid Arthritis?

Rheumatoid Arthritis, Family Planning & Pregnancy

Radiotherapy and Rheumatoid Arthritis

Rheumatoid Arthritis Complications

Hip Rheumatoid Arthritis

Rheumatoid Arthritis and Winter Weather

Rheumatoid Arthritis and Vitamin D

Rheumatoid Arthritis Support

Rheumatoid Factor Test

Total Knee Replacement and Rheumatoid Arthritis

Disease-Modifying AntiRheumatic Drugs (DMARDs)

Rheumatoid Arthritis Diet and Nutrition

Rheumatoid Arthritis Diagnosis

Juvenile Rheumatoid Arthritis Diagnosis

Rheumatoid Arthritis and Gout

Rheumatoid Arthritis and Gum Disease

Can Antibiotics Increase the Risk of Arthritis?

Knee Rheumatoid Arthritis

Rheumatoid Arthritis Research

Rheumatoid Arthritis and Depression

Rheumatoid Arthritis History

Rheumatoid Arthritis and Acupuncture

Yoga and Tai chi in Rheumatoid Arthritis

Self-Help and Living with Rheumatoid Arthritis

Causes of Hand Pain

Rheumatoid Arthritis Prognosis

Rheumatoid Arthritis and Feet

Juvenile Rheumatoid Arthritis Types

Rheumatoid Arthritis Management

Are There Any Natural Remedies for Rheumatoid Arthritis?

Latest Rheumatoid Arthritis News and Research

Air pollution may worsen rheumatoid arthritis symptoms and flare risk

A novel study shows that exposure to air pollution, especially fine particulate matter like dust, soot, and smoke (PM2.5), is associated with increased disease activity and flare risk in rheumatoid arthritis (RA).

5 Aug 2026

Australian-first twin study aims to to unlock new insights into immune health

An Australian-first study of twins will seek to find out why two genetically similar people respond differently to infections, diseases and treatments.

4 Aug 2026

New gum disease treatment kills harmful bacteria while saving beneficial microbes

Researchers at Nagoya University in Japan have created an innovative treatment for periodontitis that targets and eliminates harmful bacteria while preserving beneficial oral microbes essential for health.

4 Aug 2026

Study of lung immune cells uncovers roots of autoimmune disease

A massive analysis of immune cells in human tissue is yielding clues to the root cause of lung and autoimmune diseases.

3 Aug 2026

Mount Sinai establishes new autoimmunity center with $5 million gift

A $5 million gift from philanthropists Judith and Stewart Colton will establish a Colton Center for Autoimmunity within the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai.

21 Jul 2026

Dysregulation of immune regulator NF-κB drives major human diseases

NF‑κB controls genes involved in inflammation, immunity, cell survival, and proliferation. Triggered by cytokines (TNF‑α, IL‑1β), microbial products, or cellular stress, it translocates to the nucleus and induces pro‑inflammatory mediators.

13 Jul 2026

Monoclonal antibody shows promise for treating acute respiratory distress syndrome

Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS.

30 Jun 2026

Cryo-EM microscopy uncovers structure of bacteria behind gum disease

Periodontal (gum) disease is one of the most prevalent diseases worldwide, caused by the bacterium Porphyromonas gingivalis (P. gingivalis). In Japan alone, approximately 80% of adults over 30 years old are affected or considered at risk.

30 Jun 2026

Anti-inflammatory molecule reduces excessive alcohol consumption in female mice

The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammatory molecule, already approved by the U.S. Food and Drug Administration to treat autoimmune diseases, reduces excessive alcohol consumption in alcohol-dependent female mice.

29 Jun 2026

Immune cells drive abnormal joint tissue growth in rheumatoid arthritis

Researchers at Hospital for Special Surgery (HSS) have identified a specialized population of immune cells that play a central role in driving abnormal tissue growth in rheumatoid arthritis (RA), offering new insight into disease progression and potential treatment strategies.

24 Jun 2026

Swedish scientist wins prestigious award for sickness behavior research

David Engblom, Professor of Neurobiology at Linköping University, Sweden, is awarded the 2026 Onkel Adam Prize for outstanding research at the Faculty of Medicine at Linköping University.

24 Jun 2026

Researchers uncover key mechanism driving chronic Sjögren disease

Sjögren disease, an autoimmune disease characterized by dry mouth and dry eyes, may reduce patients’ quality of life.

24 Jun 2026

Engineered CAR-T cells offer potential rheumatoid arthritis cure

For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a reality that new research from Tsinghua University may soon begin to change.

22 Jun 2026

Aging immune cells may explain why autoimmunity rises later in life

A new Review reveals how aging can push the immune system into a paradoxical state, weaker against threats yet more prone to attacking the body’s own tissues.

21 Jun 2026

Blood-based indicator assesses organ age to predict disease risk

The candles on your birthday cake don't tell the whole story. As anyone who ever attended a high-school reunion can tell you, some people age faster than others.

15 Jun 2026

Philanthropic investment expands collaborative network for autoimmune research

NYU Langone Health today announced a new philanthropic investment from longtime supporters Judy and Stewart Colton as part of a $15 million gift shared across three Colton Consortium institutions: NYU Langone, Yale University, and Tel Aviv University.

10 Jun 2026

Review finds vitamin D lacks disease-modifying effect in rheumatic diseases

A new review from the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group, published in Osteoporosis International, provides a comprehensive evaluation of the role of vitamin D in inflammatory rheumatic diseases.

8 Jun 2026

GLP-1 therapies linked to fewer complications in adults with both obesity and autoimmune disease

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

7 Jun 2026

Patient organizations strengthen support for people with rheumatic diseases

Rheumatic and musculoskeletal diseases (RMD) are chronic, often lifelong conditions. EULAR - The European Alliance of Associations for Rheumatology - works with the network of national organizations of People with Arthritis/Rheumatism in Europe (PARE) to ensure the voices of people with RMD are heard and have influence among decision makers - creating powerful alliances that make a real difference to lives.

7 Jun 2026